Skip to main content
Premium Trial:

Request an Annual Quote

Molecula Moves to New Virginia Facility

NEW YORK, June 17 (GenomeWeb News) - Oligo manufacturer Molecula has moved into a new facility in Sterling, Va., its parent company CalbaTech said today.


The new facility will enable Molecula to become a fully compliant cGMP oligo manufacturer of siRNA and other oligo products, according to the company.


Molecula was founded in 1993 as a provider of antisense oligonucleotides. Its current product portfolio includes custom oligos, peptide services, and transfection agents.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.